Cargando…

2943. Hazardous Alcohol Use and Direct-acting Antiviral Therapy Initiation Among People Who Inject Drugs with Current Hepatitis C Infection

BACKGROUND: People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV) infection. However, HCV treatment rates among PWID remain low. Previous data suggest that hazardous alcohol use is negatively associated with direct-acting antiviral (DAA) therapy initiation in the general p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karimi-Sari, Hamidreza, Falade-Nwulia, Oluwaseun, Zook, Katie, Page, Kathleen R, Lucas, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678190/ http://dx.doi.org/10.1093/ofid/ofad500.182

Ejemplares similares

2497. Analysis of Social Determinants of Health (SDOH) and their Implications for Hepatitis C Treatment in People Who Inject Drugs: The Case of Baltimore
por: Corro, Luis A Gonzalez, et al.
Publicado: (2023)

Impact of Co-occurring Drug Use, Hazardous Alcohol Use, and Mental Health Disorders on Drug Use Patterns in People With HIV and Hepatitis C Virus Infection
por: McCormick, Sean, et al.
Publicado: (2021)

1590 Hepatitis C Care among HIV Infected Patients in a Community Based Clinic
por: Grier, Brittany, et al.
Publicado: (2014)

Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use
por: Pytell, Jarratt D., et al.
Publicado: (2023)

Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era
por: Falade-Nwulia, O, et al.
Publicado: (2016)

A22 Phylogenetic clustering of hepatitis C virus infection among people who inject drugs in Baltimore
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2019)

Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2020)

Individual and social network correlates of responding to multiple overdoses among a cohort of people who use drugs
por: Wagner, Karla D., et al.
Publicado: (2022)

1291 Sexually Transmitted Diseases Clinic Based Hepatitis C Testing and Linkage to Care
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2014)

More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD
por: Dayton, Lauren, et al.
Publicado: (2019)

A23 Population level diversification of hepatitis C viral strains over time among people who inject drugs in Baltimore, MD
por: Hackman, J, et al.
Publicado: (2019)

Awareness, perception and utilization of a mobile health clinic by people who use drugs
por: Grieb, Suzanne M., et al.
Publicado: (2022)

In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey
por: Sarıgül Yıldırım, Figen, et al.
Publicado: (2022)

A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study
por: Ward, Kathleen M, et al.
Publicado: (2019)

A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US
por: Latkin, Carl, et al.
Publicado: (2022)

Senior Center-Based Hepatitis C Screening in Baltimore
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2016)

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
por: Lima, Viviane D., et al.
Publicado: (2015)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago
por: Tatara, Eric, et al.
Publicado: (2022)

1508. The effects of the COVID-19 pandemic on depression severity and viral load non-suppression among people with HIV accessing care in an urban infectious disease clinic in Baltimore, MD
por: Verinumbe, Tarfa, et al.
Publicado: (2023)

2505. Using an Electronic Medical Record Alert to Screen Inpatient Encounters for People with Hepatitis C
por: Pryal, Patrick, et al.
Publicado: (2023)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
por: Messina, Vincenzo, et al.
Publicado: (2020)

Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens
por: Akiyama, Matthew J, et al.
Publicado: (2021)

Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review
por: Abdelwadoud, Moaz, et al.
Publicado: (2020)

Behavioral and Attitudinal Correlates of Trusted Sources of COVID-19 Vaccine Information in the US
por: Latkin, Carl A., et al.
Publicado: (2021)

Alcohol Use and Long‐Term Outcomes Among U.S. Veterans Who Received Direct‐Acting Antivirals for Hepatitis C Treatment
por: Kim, Nicole J., et al.
Publicado: (2020)

The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
por: Stone, Jack, et al.
Publicado: (2016)

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents
por: Norton, Brianna L, et al.
Publicado: (2020)

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs
por: Yeung, Alan, et al.
Publicado: (2022)

Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study
por: Salazar-Vizcaya, Luisa, et al.
Publicado: (2018)

Predicting Hazardous Alcohol Drinking Behaviors in Family Members of Hazardous Alcohol-Drinker Patients
por: Chen, Ching-Yen, et al.
Publicado: (2022)

1600. Long-Acting Antiretroviral Injectable: Who Would Benefit?
por: Pogorzelski, Karolina, et al.
Publicado: (2023)

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
por: Martin, Natasha K, et al.
Publicado: (2013)

Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting
por: Alimohammadi, Arshia, et al.
Publicado: (2018)

The impact of direct‐acting antivirals on hepatitis C viraemia among people who inject drugs in England; real‐world data 2011–2018
por: Bardsley, Megan, et al.
Publicado: (2021)

Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals
por: Rich, Zachary C., et al.
Publicado: (2016)

Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment
por: Haque, Lamia Y., et al.
Publicado: (2022)

Deep learning and social network analysis elucidate drivers of HIV transmission in a high-incidence cohort of people who inject drugs
por: Clipman, Steven J., et al.
Publicado: (2022)

Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_94mg3g47bm7go36ec5d3jaclui